Upgrade to SI Premium - Free Trial

Form 1-A POS HeartSciences Inc.

April 10, 2026 4:45 PM

ATTACHMENTS / EXHIBITS

primary_doc.xml

POST EFFECTIVE AMENDMENT NO. 1 TO FORM 1-A

SECOND AMENDMENT TO SELLING AGENT ENGAGEMENT LETTER, DATED MARCH 24, 2026, BETWEEN THE COMPANY AND DIGITAL OFFERING, LLC

CONSENT OF HASKELL & WHITE LLP

OPINION OF FOLEY SHECHTER ABLOVATSKIY LLP

Categories

SEC Filings